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UbiquinoneObjectives: To investigate how the modulation of the oxidative balance affects cytotoxic therapies in
glioblastoma, in vitro.
Material and methods: Human glioblastoma U251 and T98 cells and normal astrocytes C8D1A were
loaded with coenzyme Q10 (CoQ). Mitochondrial superoxide ion (O2) and H2O2 were measured by fluo-
rescence microscopy. OXPHOS performance was assessed in U251 cells with an oxytherm Clark-type
electrode. Radio- and chemotherapy cytotoxicity was assessed by immunostaining of cH2AX (24 h),
annexin V and nuclei morphology, at short (72 h) and long (15 d) time. Hif-1a, SOD1, SOD2 and NQO1
were determined by immunolabeling. Catalase activity was measured by classic enzymatic assay.
Glutathione levels and total antioxidant capacity were quantified using commercial kits.
Results: CoQ did not affect oxygen consumption but reduced the level of O2 and H2O2 while shifted to a
pro-oxidant cell status mainly due to a decrease in catalase activity and SOD2 level. Hif-1a was damp-
ened, echoed by a decrease lactate and several key metabolites involved in glutathione synthesis. CoQ-
treated cells were twofold more sensitive than control to radiation-induced DNA damage and apoptosis
in short and long-term clonogenic assays, potentiating TMZ-induced cytotoxicity, without affecting non-
transformed astrocytes.
Conclusions: CoQ acts as sensitizer for cytotoxic therapies, disarming GBM cells, but not normal astro-
cytes, against further pro-oxidant injuries, being potentially useful in clinical practice for this fatal
pathology.
 2018 Elsevier B.V. All rights reserved. Radiotherapy and Oncology xxx (2018) xxx–xxxGrade IV astrocytoma or glioblastoma multiforme (GBM) is the
most common type of malignant brain tumor in adults [1]. The cur-
rent therapeutic protocol for this pathology includes maximal safe
surgery, radiotherapy and chemotherapy with temozolomide
(TMZ), an alkylating agent and radiosensitizer [2,3]. Nevertheless,
even patients receiving the standard of care die early with a med-ian survival of 14 months due to recurrence within the radiation
field [1,4,5].
Several evidences link GBM radioresistance with the mitochon-
drial pathophysiology and the over-production of radical oxygen
species (ROS) scavengers, which lately determine a shift to an
antioxidative balance [6–10]. GBM cells are very glycolytic even
in normoxia: the so called ‘‘Warburg effect” [11]. In this setting,
a high level of O2 is produced and rapidly dismutated to H2O2,
which is translocated to the cytosol, orchestrating multiple mech-
anisms leading to radioresistance [12–14]. High levels of O2 and
H2O2 are toxic and thus, GBM cells increase their antioxidantcells to
2 Coenzyme Q10 improves glioblastoma treatmentdefenses as a survival mechanism, i.e. the levels of catalase and
mitochondrial superoxide dismutase (SOD2) are increased [6,7].
The cytotoxic effect of ionizing radiation is mediated by the
induction of ROS, leading to DNA and RNA damage and genomic
instability [14]. Thus, the naturally increased level of catalase
and SOD2 enzymes ameliorates radiation-induced DNA damage,
contributing to resistance to radiation-induced cell damage
[6,15]. Moreover, the increased level of reduced glutathione
(GSH) also contributes to cell protection against ROS and, thus, par-
ticipates in the resistance to ionizing radiation [16]. Indeed, there
is a negative correlation between the level of GSH and sensitivity
to ionizing radiation in a series of brain tumors including GBM
[17]. GSH level is also related to resistance to TMZ and mediates
several mechanisms of resistance development [18]. Furthermore,
high lactate levels produced by aerobic glycolysis are also intercon-
nected with radioresistance. Actually, lactate behaves as an antiox-
idant [19], being positively correlated with resistance to ionizing
radiation [14].
Instead of a single factor, radioresistance is orchestrated by sev-
eral enzymes and small molecules that are linked to the increased
generation of ROS. Therefore, the simultaneous modulation of
these ROS scavengers may be useful in GBM therapies. In this work,
we explore the role of coenzyme Q10 (CoQ) in the mechanisms
evoking radioresistance using two human GBM cell lines, U251
and T98, compared to non-transformed astrocytes C8D1A. CoQ is
a lipophilic antioxidant that crosses the blood–brain barrier [20].
Besides, it is a component of the mitochondrial electron transport
chain (ETC) that dampens the O2 generated by complex I in dys-
trophic mitochondria [12]. Our results show that treatment of
human U251 GBM cells with CoQ did not affect OXPHOS, but
slightly increased oxygen consumption associated with the mito-
chondrial complex I, which was paralleled by a decrease in the
level of mitochondrial O2 and cytosolic H2O2. Conversely, these
reactive species were increased upon irradiation in GBM cells,
but not in non-transformed astrocytes. Indeed, CoQ sensitized cells
to radiation-induced DNA damage and apoptosis both in short- and
long-term clonogenic assays. These effects are mediated by a shift
in the oxidative balance toward pro-oxidant conditions, which
relies on the reduction in catalase activity, a decrease in SOD2 level
and a cut down in intracellular lactate and key metabolites
involved in glutathione synthesis, which could be related to the
reduced level of Hif-1a. On the other hand, neither SOD1 nor
NQO1 levels were altered. These changes result in a reduction in
the total antioxidant cellular capacity and a shift to a pro-oxidant
cellular state that disarms GBM cells against further pro-oxidant
injuries induced by standard therapies, without affecting non-
transformed astrocytes. Our results indicate that CoQ combined
with radiation and TMZ has a promising potential for improving
the current therapeutic protocol for GBM.Material and methods
Reagents
Coenzyme Q10 was provided by Kaneka Corporation. TMZ,
Hoechst, crystal violet, EDTA, methanol, DMSO, dH2O, Tris–HCl,
DTT and other general reagents were acquired from Sigma–Aldrich.Cell culture and irradiation
Human GBM U251 and T98 and non-transformed astrocytes
C8D1A were obtained from ATCC and maintained under normoxia
in DMEM (Sigma–Aldrich) at 37 C and 5% CO2. For irradiation pur-
poses, cells were seeded in 24 well plates and pre-treated for 24 h
with CoQ or vehicle (ethanol; control). Depending on the experi-
ment, cells were treated with TMZ (50 lM) or vehicle (DMSO)Please cite this article in press as: Frontiñán-Rubio J et al. Regulation of the oxi
radiation and temozolomide. Radiother Oncol (2018), https://doi.org/10.1016/and again 24 h later cells were irradiated in a Gulmay D 3150
(NCA) at doses ranging between 1 and16 Gy (1.211 Gy/min) at
100 kV tube potential. Different parameters were evaluated imme-
diately after irradiation (O2 and H2O2), at 24 h (DNA damage), at
96 h (apoptosis) or at 15d (colonies formation) of irradiation.OXPHOS performance
Oxygen consumption in intact or digitonin-permeabilized cells
was determined with an oxytherm Clark-type electrode (Hansat-
ech Instruments, Norfolk, UK) as previously described [21]. Briefly,
U251 cells were resuspended in culture medium or respiration buf-
fer (10 mM MgCl2, 250 mM Sucrose, 20 mM HEPES pH 7.4, 1 mM
ADP, 2 mM KH2PO4), respectively. Oxygen consumption was
recorded at 37 C with stirring. 7.5 mM carbonyl cyanide-4-(trifluor
omethoxy)phenylhydrazone (FCCP) was used to uncouple respira-
tion in intact cells. For polarographic measurements, cells were
permeabilized with 1% digitonin (1.2 ul/106 cells) for 10 min at
37 C and oxygen consumption was recorded after the addition
of substrates and inhibitors for Complex I (5 mM Glutamate plus
5 mM Malate, and 2 mM Rotenone), Complex II + III (5 mM Succi-
nate plus 5 mM Gliceraldehide-3-P, and 0.1 mM Antimycin A) and
Complex IV (1.2 mM TMPD, and 6 mM KCN). Reactions were termi-
nated by the addition of 6 mM KCN to assess any O2 consumption
not derived from the respiratory chain.Single-cell determination of O2
 and H2O2
Mitochondrial O2 and total H2O2 levels were determined with
MitoSOX and H2DCFDA probes, respectively (Life Technologies).
Cells were seeded in 96 well plates and incubated for 24 h with
vehicle (control) or CoQ (2.5–10 lM) and then irradiated as indi-
cated above. Then, cells where immediately loaded for 30 min with
1 lM MitoSOX or H2DCFDA, washed in fresh medium and imaged
in a Nikon TiU microscope (20 objective). Images were analyzed
and processed with ImageJ software (NIH). Results are expressed
as the percentage of cell signal vs. control (minimum 50 cells,
n = 3).Determination of total antioxidant capacity
Cells were seeded in 96 well plates and incubated for 24 h with
vehicle (control) or CoQ (5 lM). Total antioxidant capacity was
determined in cell lysates and in culture media using a commercial
kit, following the manufacturer‘s instructions (MAK187, Sigma–
Aldrich). Results were expressed as nmol/lg of protein (n = 4).Determination of DNA damage, apoptosis and viability
Cells treated with CoQ and irradiated, after 24 and 72 h for DNA
damage and apoptosis and viability assays, respectively, were fixed
for 2 min in 4% para-formaldehyde (PFA), stained with 1 lg/ml
Hoechst and immunolabeled for annexin V (1:500; BD Pharmin-
gen) and cH2AX antibody (1:500; Santa Cruz Biotechnology). For
cH2AX staining, cells were permeabilized for 2 min in ice-cold
methanol after PFA fixation. Binding of primary antibodies was
detected with fluorescence-labeled secondary antibodies conju-
gated with Alexa-594 (1:2000; Life Technologies). Apoptotic nuclei
were determined from Hoechst-stained nuclei images according to
morphometric criteria with ImageJ. Those cells exhibiting normal,
non-apoptotic, nuclei morphology were considered as viable.
Results are shown as percentage of apoptotic vs. total cells (at least
100 cells, n = 4). DNA damage was determined and represented as
the number of cH2AX foci per cell (at least 100 cells, n = 4). Apop-
totic cells were determined according to annexin V level. Resultsdative balance with coenzyme Q10 sensitizes human glioblastoma cells to
j.radonc.2018.04.033
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100 cells, n = 4).Clonogenic assays
Cells, seeded at 200 cells/well in 24 well plates, were treated as
indicated in paragraph above. At 15 days from irradiation, cells
were fixed for 2 min in cold methanol and stained with 0.01%
(w/v) crystal violet for 30 min. Dishes were dried and colonies con-
taining more than 50 individual cells determined using bright field
microscopy with a Nikon TiU microscope (2 objective) (n = 3).Sensitivity to exogenous H2O2
Cells were seeded to subconfluence in 96 well plates and incu-
bated for 24 h with vehicle (ethanol; control) or 5 lM CoQ. Then,
cells were treated with increasing concentrations of H2O2 (12.5–1
00 lM) and 8 h later cells were fixed and permeabilized for 2
min in ice-cold methanol and stained with 1 lg/ml Hoechst. The
number of adhered cells was counted from fluorescence micro-
scopy images. Results were computed as the percentage of cells
vs. control (at least 300 cells, n = 5).Catalase activity
Cells were seeded in 6 well plates and incubated for 24 h with
vehicle (ethanol; control) or 5 lM CoQ. Proteins were extracted
with a lysis buffer (Tris–HCl 10 mM, EDTA 1 mM & DTT 0.1 mM).
Catalase activity was quantified by spectrophotometric assays as
previously described elsewhere [22] and the fold change in cata-
lase activity vs. control conditions (n = 3) computed.Quantification of SOD1, SOD2, NQO1 and Hif-1a
Cells were seeded in 6 well plates and incubated for 48 h with
vehicle (ethanol; control) or 5 lM CoQ. Proteins were extracted
with SDS–DTT buffer. The level of SOD2, SOD1, NQO1 and Hif-1a
(1:1000 dilution, Santa Cruz Biotechnology) was quantified by
western blot as described before [23]. Results are expressed as
the mean band intensity vs. actin and normalized to control condi-
tion (n = 4). The level of Hif-1a was also measured by quantitative
immunocytochemistry and epifluorescence and the results
expressed as the mean cell-fluorescence intensity normalized to
control (at least 50 cells, n = 4).Determination of metabolites by Nuclear Magnetic Resonance (NMR)
NMR experiments were carried out on a Varian VNMRS-400
NMR system using a nanoprobe with rotors of 40 mL. 1D and 2D
NMR experiments were recorded for peak identification. Chenomx
Profiler (Chenomx Inc.) was used to assist in peak identification.
TSP was used as internal standard for quantification of metabolites.
The NMR spectra were processed with Mestrenova (Mestrelab
Research). Cells were grown onto 25 cm2 flasks and treated for
24 h with vehicle (ethanol; control) or 5 lM CoQ. The level of lac-
tate, glutamate, glycine, serine and glutamine was assessed as
described before [24].Glutathione determination
Cells were grown in 25 cm2 flasks and incubated for 24 h with
vehicle (ethanol; control) or 5 lM CoQ. Reduced (GSH) and oxi-
dized (GSSG) glutathione were determined as described before
[25]. Both absolute GSH and GSSG values and the GSSG/GSH ratio
(n = 4) were computed.Please cite this article in press as: Frontiñán-Rubio J et al. Regulation of the oxi
radiation and temozolomide. Radiother Oncol (2018), https://doi.org/10.1016/Radiobiological parameter in the dose–response curves
Dose–response curves for cell viability were fit using a Lineal-
quadratic model for the surviving fraction SF(D) = exp(-aD-bD^2).
a and b were fit using least squares methods from the data on
response to intermediate doses considering realistic values for a/b.Statistical analysis
Data are expressed as mean ± S.E.M. obtained from, at least,
three independent experiments. Statistical analysis was carried
out with GraphPad Prism 6, using Student’s t-test or a one-way
ANOVA (Kruskal–Wallis’ test) followed by a statistical test for mul-
tiple comparisons (Dunn’s test). Differences were considered sig-
nificant at p < 0.05. Results were analyzed for synergism using
the combination index method calculated by CompuSyn V 1.0,
obtaining the values for the coefficient of interaction (CI; 0.1–0.3,
strong synergism; 0.3–0.7, synergism; 0.7–0.85, moderate syner-
gism; 0.85–0.9, slight synergism and 0.9–1, nearly additive) and
the fractional effect (FE).
Results
CoQ potentiates radiation-induced rise in O2
 and H2O2 levels and
decreases the total antioxidant cell capacity in GBM cells
We first explored the effect of the incubation of human U251
and T98 cells and non-transformed astrocytes C8D1A with 5 lM
CoQ on the levels of mitochondrial O2 and H2O2 both under basal
conditions and upon irradiation. Our results show that a 24 h pre-
treatment with CoQ reduced the levels of both reactive species by
45% and 35%, respectively, in non-irradiated U251 cells (Fig. 1A). A
similar albeit lower reduction (of about 15% and 14% respectively)
was observed in T98 cells (Fig. 2B), whereas no significant decrease
was detected in non-transformed astrocytes C8D1A (Fig. 1C). How-
ever, U251 cells treated with CoQ showed significantly higher
levels of O2 and H2O2 than untreated cells after irradiation. In this
setting, mitochondrial O2 was increased by 1.2 and 1.4-fold for 2
and 4 Gy, respectively, in CoQ-treated vs. non-treated cells
(Fig. 1A and Supplementary Fig. 1). Similar results were obtained
for H2O2. In CoQ-treated cells, H2O2 levels increased 1.35-fold at
2 Gy and 1.3-fold at 4 Gy vs. non-treated cells (Fig. 1A). Comparable
results were obtained for T98 cells, being significant only at 4 Gy
dose for O2 (Fig. 1B). Opposingly, levels of both O2 and H2O2 were
significantly reduced after irradiation in CoQ-treated non-
transformed astrocytes (Fig. 1C). This dual effect of CoQ observed
in GBM cells was due to the modulation of total antioxidant cell
capacity. Indeed, U251 and T98 cells treated with CoQ showed a
15% decrease in the total antioxidant capacity vs. non-treated cells,
which reflects a shift to a pro-oxidant cell state, whereas no change
was detected in the culture media (Fig. 1D and E).CoQ enhances radiation-induced DNA damage and apoptosis
Since incubation of GBM cells with CoQ increased the level of
radiation-induced O2 and H2O2, we next studied the effect of this
compound on DNA damage in control and CoQ-treated U251 cells,
by measuring the number of c-H2AX foci per cell after irradiation.
We observed an average of 3.5 positive foci/cell in irradiated con-
trol cells, and preincubation with 5 lM CoQ for 24 h increased by
2.7-fold the number of positive c-H2AX foci at 24 h from irradia-
tion (Supplementary Fig. 2A). This exacerbation of DNA damage
was translated into an increased pro-apoptotic effect of radiation,
measured as annexin V exposure at the external hemi-layer of
the plasma membrane. Radiation induced an average of 7.94 rela-
tive fluorescence units (RFU) in irradiated control cells and this
value was increased by 13.6-fold in cells that had been preincu-dative balance with coenzyme Q10 sensitizes human glioblastoma cells to
j.radonc.2018.04.033
Fig. 1. Effect of exogenous CoQ on oxidative stress and radiation-induced cell
damage in human GBM cells and non-transformed astrocytes, in vitro. Cells were
incubated with 5 mM CoQ for 24 h and then irradiated (0–4 Gy). O2 (A–C, left
graphs) and H2O2 (A–C, right graphs) levels were quantified by fluorescence
microscopy with the probes MitoSOX and H2DCFDA, respectively. Results are
expressed as the percentage of cell signal vs. control, 0 Gy, non-treated and non-
irradiated for GBM U251 and T98 cells (A and B) and non-transformed astrocytes
C8D1A (C). min = 50 cells, n = 3, * p < 0.05; ** p < 0.005. Total antioxidant cell and
supernatant capacities, TAC, was determined by colorimetry in GBM U251 and T98
cells (D and E). Results are expressed as nmol normalized to protein concentration,
quantified by BCA. n = 4, ** p < 0.005.
4 Coenzyme Q10 improves glioblastoma treatmentbated for 24 h with 5 lM CoQ and measured 96 h after irradiation
(Supplementary Fig. 2B). Indeed, this increase in annexin V staining
and apoptosis was translated into a decrease in cell viability
(Fig. 2A, left graph). Radiation alone reduced GBM cell viability
by 35% and 50% at 2 and 4 Gy, respectively, and preincubation with
CoQ diminished cell viability by 60% and 70% for the same radia-
tion doses (Fig. 2A, left graph). Indeed, the IC50 was reduced from
2.5 in control conditions to 1.3 Gy in cells preincubated with CoQ
(Fig. 1F). Thus, CoQ almost doubled the cytotoxic effect of radiation
measured after 96 h. The radiobiological response parameters for
both curves were a = 0.1100 and b = 0.0120 (CoQ-treated) and a
= 0.02 and b = 0.12 (control) suggesting much weaker single-
strand break repair mechanisms mediated by CoQ (term linear in
the dose D). The data were very well described with the standard
Linear-quadratic model for the surviving fraction. This reductionPlease cite this article in press as: Frontiñán-Rubio J et al. Regulation of the oxi
radiation and temozolomide. Radiother Oncol (2018), https://doi.org/10.1016/in cell viability exerted by CoQ upon radiation was reproduced in
T98 cells (Fig. 2A, middle graph), whereas no effect was shown in
non-transformed C8D1A astrocytes (Fig. 2A, right graph).CoQ improves the long-term cytotoxic effect of radiation
To check the remaining viable cells’ ability to regrow, we per-
formed clonogenic assays. Human GBM cells were preincubated
with vehicle or CoQ 24 h before irradiation and were then irradi-
ated with a single dose of 1, 4 or 8 Gy. Cells were cultured for
15 days and then stained to count the number of clones in each
well. In control U251 and T98 cells, radiation alone reduced the
surviving fraction by 15% and 35% at 4 Gy and by 60% and 68% at
8 Gy, respectively (Fig. 2B, left and middle graphs and Supplemen-
tary Fig. 3A and B). Preincubation with CoQ reduced the surviving
fraction by 48% and 55% for 4 Gy and by 81% and 76% at 8 Gy,
respectively, thus triplicating the effect obtained for control cells
at 4 Gy (Fig. 2B, left and middle graphs). On the other hand, CoQ
did not affect the surviving fraction in non-transformed C8D1A
astrocytes, but even induced a slight, although statistically not sig-
nificant, protective effect (Fig. 2B, left and middle graphs and Sup-
plementary Fig. 3C). Our results show that the CoQ-mediated
radiosensitization of GBM cells involves an exacerbation of lethal
DNA damage that cannot be repaired by these tumor cells.CoQ does not affect oxygen consumption but reduces lactate and
Hif-1a levels
As complex I in tumor cells dystrophic mitochondria generates
high amounts of O2 radicals [12] and our results have shown that
CoQ diminishes the level of this radical species (Fig. 1A and B), we
wondered if mitochondrial respiration was affected upon addition
of the antioxidant. Incubation of GBM U251 cells with 5 lM CoQ
did not modify neither endogenous nor uncoupled oxygen con-
sumption (Fig. 3A), though it slightly increased oxygen consump-
tion associated with complex I from 0.59 to 0.96 fmol/min/cell
(Fig. 3B).
Considering that GBM are highly glycolytic and intracellular
lactate level is involved in radioresistance [11,14], we then mea-
sured the level of intracellular lactate in U251 cells treated for
24 h with vehicle (control) or 5 lM CoQ showing a decrease in lac-
tate by 46% vs. control (Fig. 3C). This decrease was paralleled by a
40 and 25%-reduction in U251 and T98 cells, respectively, in the
level of the transcription factor Hif-1a, the main inductor of gly-
colytic metabolism upon CoQ pretreatment (Fig. 3D and E). On
the other hand, the level of Hif-1a was not affected by CoQ treat-
ment in non-transformed astrocytes C8D1A (Fig. 3F).CoQ reduces catalase activity and the level of SOD2 but does not
modify the levels of SOD1 or NQO1
Exacerbated ROS levels lead to an increase in the level of antiox-
idant phase II enzymes, including catalase and SOD2 [6,7]. Since
CoQ reduced the total antioxidant cell capacity and increased the
level of both O2 and H2O2 in GBM cells after irradiation, we won-
dered if these phase-II antioxidant enzymes were downregulated.
Incubation of human GBM cells with CoQ ranging from 2.5 to 10
lM reduced catalase activity between 35–50% and 25–50% in
U251 and T98 cells, respectively, which was not affected in non-
transformed astrocytes (Fig. 4A). Also, human GBM cells preincu-
bated with 5 lM CoQ were more sensitive than control cells to
cytotoxicity of exogenous H2O2, obtaining IC50 values of 3 and 8
lM in U251 and 12.7 and 25.3 lM in T98 for CoQ-treated or con-
trol cells, respectively, whereas no difference was found for non-
transformed astrocytes C8D1A (Fig. 4B). Similarly, the level of
SOD2 polypeptide was reduced by 40% after CoQ treatment indative balance with coenzyme Q10 sensitizes human glioblastoma cells to
j.radonc.2018.04.033
Fig. 2. CoQ reduces radiation-induced cell viability at short and long term in human GBM U251 and T98 cells but not in non-transformed astrocytes C8D1A, in vitro. Cells
were incubated with 5 mM CoQ for 24 h and then irradiated (0–8 Gy). (A) Cell viability was calculated from fluorescence microscopy images, attending cell nuclei morphology.
Results are expressed as percentage of decrease vs. control, non-treated and non-irradiated for GBM U251 (A, left) and T98 cells (A, middle) and non-transformed astrocytes
C8D1A (A, right). min = 100 cells, n = 4, * p < 0.05; ** p < 0.005; *** p < 0.001. (G) For clonogenic assays, cells were incubated with 5 mM CoQ for 24 h and then irradiated
(0–8 Gy). The number of clones was determined at 15d from irradiation, by staining with crystal violet and counting. Results are expressed as the surviving fraction vs. control
non-treated and non-irradiated for GBM U251 (B, left) and T98 cells (B, middle) and non-transformed astrocytes C8D1A (B, right). n = 4, * p < 0.05; ** p < 0.005.
J. Frontiñán-Rubio et al. / Radiotherapy and Oncology xxx (2018) xxx–xxx 5U251 and T98 cells, whereas it was not affected in C8D1A cells
(Fig. 4C–E). Neither SOD1 nor NQO1 was altered in U251 cells
(Fig. 4C).CoQ regulates the synthesis of glutathione
Glutathione is one of the main cellular antioxidants, being its
synthesis upregulated during oxidative stress [16]. An increased
level of oxidants such as H2O2 causes short-term falls in intracellu-
lar GSH, which is associated with higher levels of GSSG [16]. Our
results in human U251 cells show that the level of GSH was neither
altered by treatment with vehicle (control) nor with CoQ (Supple-
mentary Fig. 4A, left). However, CoQ significantly decreased the
level of GSSG (Supplementary Fig. 4A, middle), which resulted in
a decrease in GSSG/GSH ratio (Supplementary Fig. 4A, right) and
in a smaller glutathione-antioxidant capacity of CoQ-treated cells.
This change in the whole glutathione pool could be due to the low-
ering of critical amino acids essential for the synthesis of the
antioxidant, glutamate, glycine, serine and glutamine, all of them
reduced by 42%, 52%, 50% and 40%, respectively, in CoQ-treated
vs. control cells (Supplementary Fig. 4B).CoQ potentiates TMZ in the radiosensitization of human GBM cells
TMZ, the standard chemotherapeutical in the clinical manage-
ment of GBM, is known to have also a radiosensitizing effect [2].
We have analyzed the interaction between TMZ and CoQ on
radiation-induced cytotoxicity in U251 and T98 cells compared
to non-transformed C8D1A astrocytes. In U251 cells, CoQ or TMZPlease cite this article in press as: Frontiñán-Rubio J et al. Regulation of the oxi
radiation and temozolomide. Radiother Oncol (2018), https://doi.org/10.1016/alone increased radiation-induced apoptosis by 13% and 17%,
respectively, whereas the combined treatment with CoQ and
TMZ increased radiation-induced apoptosis in 28% vs. cells treated
with vehicle, at 4 Gy with a fractional effect of 0.58 and CI of 0.22
showing strong synergism (Supplementary Fig. 5, left and Supple-
mentary Table 1). In T98 cells, CoQ or TMZ alone increased
radiation-induced apoptosis by 12% and 6%, being CoQ + RT-medi
ated effect more effective than TMZ + RT. Combined treatment
with CoQ and TMZ increased radiation-induced apoptosis in 17%
vs. cells treated with vehicle, at 4 Gy with a fractional effect of
0.51 and CI of 0.68 showing moderate synergism (Supplementary
Fig. 5, middle and Supplementary Table 1). No difference was
found between treatments for non-transformed C8D1A astrocytes
(Supplementary Fig. 5, right).Discussion
Radioresistance is a hallmark of GBM [6–10]. Even with the cur-
rent treatment that encompasses maximal function-preserving
surgery followed by TMZ concomitant with radiotherapy (Stupp’s
protocol), the tumor regrows within the radiation field [1,3–5].
Radioresistance is orchestrated by multiple and interconnected
factors, including the recruitment of different antioxidant systems
due to the overproduction of high levels of O2 and the glycolytic
metabolism and [1,6,7]. Here we describe a novel combined treat-
ment for GBM, in vitro, using CoQ as radiosensitizer, targeting
mitochondrial O2 and H2O2, diminishing the total antioxidant cell
capacity by reducing the level of catalase, SOD2, glutathione anddative balance with coenzyme Q10 sensitizes human glioblastoma cells to
j.radonc.2018.04.033
Fig. 3. CoQ does not affect OXPHOS but reduces the level of intracellular lactate and Hif-1a in GBM cells, in vitro. Cells were incubated with 5 mM CoQ for 24 h. Oxygen
consumption in intact or digitonin-permeabilized cells was determined with an oxytherm Clark-type electrode. (A) FCCP was used to uncouple respiration in intact cells. (B)
For polarographic measurements, cells were permeabilized with 1% digitonin and oxygen consumption was recorded after the addition of substrates and inhibitors for
Complex I (5 mM Glutamate plus 5 mMMalate, and 2 mM Rotenone), Complex II + III (5 mM Succinate plus 5 mM Gliceraldehide-3-P, and 0.1 mM Antimycin) and Complex IV
(1.2 mM TMPD, and 6 mM KCN). Results are expressed as fmol O2/min/cell. n = 4, * p < 0.05. (C) Intracellular lactate level was quantified by Nuclear Magnetic Resonance
(NMR) in U251 cells. Results are expressed as % decrease vs. control. n = 4, ** p < 0.005. (D) The level of Hif-1a was quantified in U251 and T98 GBM cells and in C8D1A non-
transformed astrocytes by immuno-techniques with an anti- Hif-1a antibody. n = 4, ** p < 0.05.
6 Coenzyme Q10 improves glioblastoma treatmentlactate, by mechanisms involving a reduction in the level of Hif-1a,
improving the overall response to radiotherapy and TMZ in vitro,
which targets specifically tumor cells without affecting non-
transformed astrocytes.
CoQ is a lipophilic antioxidant that crosses the blood–brain bar-
rier [20,26]. Exogenous CoQ is first accumulated in the endo-
lysosomal compartment, and then rapidly becomes incorporated
to mitochondria-associated membranes and mitochondria [26].
In this organelle, CoQ participates in oxidative phosphorylation
under normal conditions, whereas under pathological conditions,
as in tumor cells, it diminishes the high levels of O2 generated
by complex I [12]. In this context, our results show that the prein-
cubation of GBM cells with CoQ diminished by 50% the level of
mitochondrial O2 and, in parallel, the level of H2O2 (Fig. 1A and
B), increasing oxygen consumption associated with mitochondrial
complex I, without affecting the overall respiration rate (Fig. 3A
and B). Since complex I is considered to be one of the main cellular
sources of ROS production and both the increase and the decrease
in its enzymatic activity have been previously related to this pro-
cess [27], our results could agree with a model that is associated
with the reduction in oxidative stress by favoring the non-
accumulation of reducing power.
Elevated O2 and H2O2 levels are toxic to normal cells [28].
However, cancer cells overcome high levels of ROS by turning on
multiple antioxidant systems that also protect cells from furtherPlease cite this article in press as: Frontiñán-Rubio J et al. Regulation of the oxi
radiation and temozolomide. Radiother Oncol (2018), https://doi.org/10.1016/pro-oxidant stimuli, as radiation [28]. Cancer cells take advantage
of the situation since O2 and H2O2 can also sustain proliferation
[29]. Our results indicate that CoQ can deactivate several of these
antioxidant systems, reflected by a decrease in the total cell antiox-
idant capacity.
We have shown that CoQ reduces by almost 50% the level of
intracellular lactate (Fig. 3C), possibly regulating the Warburg
effect. Intracellular lactate has an antioxidant role by dampening
free oxygen radicals induced by radiation [14,19]. Thus, CoQ-
mediated lactate decrease seems to contribute to the elevated
O2 and H2O2 levels induced by radiotherapy (Fig. 1A and B), lead-
ing to an enhanced DNA damage and apoptosis (Supplementary
Fig. 2). Moreover, lactate is one of the main energy sources of
GBM cells [14,30]. Thus, the CoQ-mediated lowering of the lactate
levels may be associated with the small but significant decrease in
cell viability in non-irradiated vs. non-treated cells (Fig. 2A, left).
This effect could be related to the decrease observed in Hif-1a level
after incubation with CoQ (Fig. 3D and E). Multiple evidences
pointed toward Hif-1a as the main driver for glycolytic metabo-
lism and radioresistance [31–33]. Hif-1a changes glucose metabo-
lism toward a glycolytic phenotype. Indeed, the inhibition of Hif-
1a results in a decreased rate in glucose uptake, lactate production
and an increase in oxygen consumption, which denotes an
enhanced mitochondrial oxidation [34,35]. In this sense, our
results indicate that CoQ is reducing the level of Hif-1a (Fig. 3Ddative balance with coenzyme Q10 sensitizes human glioblastoma cells to
j.radonc.2018.04.033
Fig. 4. CoQ reduces catalase activity and SOD2 polypeptide sensitizing human GBM cells but not non-transformed astrocytes to H2O2-induced cell death, in vitro. Cells were
incubated with 5 mM CoQ for 24 h. Catalase was determined following spectrophotometric procedures and expressed as % vs. control, non-treated, in GBM U251 (A, left) and
T98 (A, middle) cells and in non-transformed astrocytes C8D1A (A, right). Control and CoQ-treated cells were incubated for 8 h with increasing H2O2 concentrations (12.5–
100 lM) and then, washed and fixed. Results show the % of cells attached to the culture dish vs. control in U251 (B, left) and T98 (B, middle) cells and in non-transformed
astrocytes C8D1A (B, right). Western blot and densitometric analysis showed a decrease in SOD2 and no variation in SOD1 and NQO1 in U251 cells (C). SOD2 level is also
decreased in T98 cells (D) but unaffected in non-transformed C8D1A astrocytes (E). n = 4, * p < 0.05; ** p < 0.005.
J. Frontiñán-Rubio et al. / Radiotherapy and Oncology xxx (2018) xxx–xxx 7and E), which agrees with the reduction observed in the level of
lactate (Fig. 3C), probably also related to the slight increase in oxy-
gen consumption associated with the mitochondrial complex I
(Fig. 3A). Furthermore, H2O2 is sufficient to stabilize HIF-1a proteinPlease cite this article in press as: Frontiñán-Rubio J et al. Regulation of the oxi
radiation and temozolomide. Radiother Oncol (2018), https://doi.org/10.1016/under normoxia [36,37] and preincubation of U251 and T98 cells
with CoQ reduced the levels of H2O2. As a whole, CoQ contributes
to radiosensitize GBM cells through modulation of Hif-1a, lactate
level and probably mitochondrial respiration.dative balance with coenzyme Q10 sensitizes human glioblastoma cells to
j.radonc.2018.04.033
8 Coenzyme Q10 improves glioblastoma treatmentA search in the TCGA and Murat series included within the
Oncomine database (https://www.oncomine.org/resource/ login.
html) shows that catalase and SOD2 levels are increased in
glioblastoma vs. normal brain (Supplementary Figs. 6 and 7)
whereas SOD1 and NQO1 levels are not altered (Supplementary
Figs. 8 and 9). Our results show a decrease in catalase activity
and 44% reduction in SOD2 polypeptide level in human GBM cells
but not in non-transformed astrocytes (Fig. 4C–E). Conversely, CoQ
neither alters the levels of SOD1 nor NQO1 (Fig. 4C). CoQ has been
shown to inhibit deregulated catalase activity and SOD2 levels in a
model of DMBA induced breast cancer [38] as well as in a model of
diabetic rats, a non-tumor disease with a strong oxidative compo-
nent [39]. To our knowledge, there was no previous evidence that
CoQ reduces catalase and SOD2 levels in GBM cells. It is known that
an increase in catalase and SOD2 activities is linked to radioresis-
tance in human GBM U251 cells [6], and that the inhibition of
the enzymes sensitizes rat glioma cells to apoptosis induced by
pro-oxidant injuries [40]. Lessening of catalase and SOD2 by CoQ
combined with the reduced intracellular lactate level could be
related to the radiosensitization and potentiation of both, short
and long-term radiation-induced apoptosis reported here (Fig. 2A
and B).
GSH is the most abundant non-enzymatic antioxidant molecule
in the cell, essential for cell survival and redox homeostasis [28]. It
protects the cell against O2 and H2O2-induced oxidation, but it is
likewise involved in cancer cell-resistance to ionizing radiation
[16]. Indeed, the level of GSH is negatively correlated to the sensi-
tivity of brain tumors to radiation [17]. There is no previous evi-
dence of GSH regulation by CoQ in tumor pathologies. However,
CoQ reduced the level of hepatic GSH triggered by ischemia-
reperfusion in a rat model of the disease [41]. Our results show that
CoQ clearly diminished the oxidized form of glutathione, GSSG, and
the ratio GSSG/GSH (Fig. 3G). Thus, CoQ decreased the total and
effective amounts of glutathione, probably through inhibition of
glutamate, glycine, serine and glutamine levels (Supplementary
Fig. 4), all of them being key precursor metabolites of glutathione
synthesis [28]. Our results show that the reduction in total glu-
tathione level could be involved in the sensitization of GBM cells
to pro-oxidant stimuli, as radiation (Fig. 1). Glutathione is also
related to the TMZ-induced bystander effect described in GBM pre-
viously [18]. TMZ is the standard chemotherapeutic for the treat-
ment of GBM, concomitant with surgical resection and/or
radiotherapy [2,3]. While many mechanisms contribute to the
development of resistances, it is known that small fractions of
resistant cells can induce a general resistance to temozolomide
by mechanisms that involve an increase in the antioxidant machin-
ery [18]. This effect can be reversed by glutathione-depleting
agents. Our results show that CoQ reduces the effective amount
of glutathione, sensitizing, in parallel, GBM cells, but not astro-
cytes, to TMZ in non-irradiated cells (Supplementary Fig. 5), which
suggests that this action could be due to the mechanism reported
hitherto [15]. It is interesting to note that computer simulations of
mathematical models of GBM growth have predicted that the
effect of an antioxidant therapy with the properties reported here
may have a major effect on the evolution of the disease when other
factors are taken into account [42].
Our results reported herein provide the first evidence, in vitro,
that CoQ radiosensitizes and potentiates TMZ cytotoxicity, induc-
ing apoptosis in human GBM cells, without affecting normal astro-
cytes, by regulating, simultaneously, intracellular lactate and Hif-
1a, catalase activity and SOD2 and glutathione levels. Thus CoQ,
known as antioxidant, can diminish the total antioxidant cell
capacity deactivating the cell antioxidant machinery. CoQ emerges
as an attractive molecule for combined therapies with radiation
and TMZ aimed to improve the prognosis of patients suffering this,
nowadays, fatal pathology.Please cite this article in press as: Frontiñán-Rubio J et al. Regulation of the oxi
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